Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lindus Health

Explore full profile

Accelerates clinical trials for biotech and healthtech pioneers

London, United KingdomFounded 2021Biotech & Life Sciences
Valuation $100–250M Last recorded · 2025
Revenue $1–10M Latest reported FY
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Lindus Health and the history behind them.

About Lindus Health

Lindus is a next-generation contract research organization (CRO) purpose-built to give biotech and pharmaceutical sponsors genuine confidence and control over their clinical trials. At the core of its offering is Citrus™, an AI-assisted trial operating system with clinical oversight that connects patient identification across 40 million electronic health records to full-scope trial execution across the US and UK. Rather than managing complexity with more complexity, Lindus is engineered to surface risks early — integrating recruitment, study operations, and clinical data into a single system visible to both sponsors and internal teams in real time. The result is a model where one partner carries one clear line of accountability, from study design through database lock.

Read full description

The company has delivered over 45 trials spanning cardiometabolic, respiratory, psychiatry, dermatology, women's health, and diagnostics — and the performance speaks for itself. In trials where Lindus owned enrollment, 82% completed on or ahead of the timeline presented at proposal, compared to an industry average closer to 20%. Milestone-based payment terms align financial incentives around timely delivery and budget discipline, making Lindus a genuine partner rather than a vendor. Backed by leading investors and advisors including Peter Thiel and Prof. Robert S. Langer, and recognized with awards for outstanding patient recruitment, Lindus is setting a new standard for accountability in clinical trial execution.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
London, United Kingdom
Employees
216
Open positions
8
Dealroom signal
93.0/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Clinical, Core AI, Clinical Trials, Tech for Hospitals and Clinics, EIT Health, AI Drug Discovery
Technology
Artificial Intelligence, Machine Learning
Business model
SaaS
Client focus
b2b

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Jan 2025 $55M $220M Seedcamp · Firstminute Capital · Balderton Capital · Creandum ↗
SERIES AOther financing Aug 2023 $18M $72M Soraya Darabi · Firstminute Capital · Trevor Martin · Amino Collective ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Lindus Health website traffic

Latest recorded traffic for Lindus Health is 41K monthly website visits, down 75.9% over the last three months. Lindus Health's team grew 3.8% over the past year.

Latest monthly visits41K 3-month web change-75.9% 1-year team growth+3.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

Series A8 investors entered at this stage

Other known investors2 additional known investors

  • EIT Health
  • KQ Labs
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇬🇧 United Kingdom61.1%
🇺🇸 United States29.6%
🇩🇪 Germany6.8%
🇫🇷 France1.2%
🇸🇪 Sweden0.6%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lindus Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lindus Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.